Green tea, phytomedicine against influenza A: Role of catechins;Té verde, Fitomedicamento contra la Influenza A: Rol de las Catequinas

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas

Volumn 11, Issue 2, 2012, Pages 106-110

  Bustamante, Sandro ^a   Morales, Miguel ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Camelia sinensis; Green tea; Influenza A; Phytodrugs; Viral endonuclease

Indexed keywords

ANTIVIRUS AGENT; CATECHIN; ENDONUCLEASE; RNA DIRECTED RNA POLYMERASE; SIALIDASE INHIBITOR;

ANTIVIRAL ACTIVITY; AVIAN INFLUENZA; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG SAFETY; EDITORIAL; INFLUENZA A; INFLUENZA VIRUS A; NONHUMAN; PANDEMIC INFLUENZA; PHYTOCHEMISTRY; TEA; VIRUS REPLICATION; VIRUS RESISTANCE;

AVES; INFLUENZA A VIRUS; SUIDAE;

EID: 84859095176     PISSN: None     EISSN: 07177917     Source Type: Journal    
DOI: None     Document Type: Editorial

References (21)

1. Bardage C, Persson I, Örtqvist Å, Bergman U, Ludvigsson JF, Granath F. 2011. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ 343: d5956
2. Cabrera C, Artacho R, Giménez R. 2006. Beneficial Effects of Green Tea. A Review. J Am Col Nut 25: 79-99.
3. Córdoba JA, Hernández M, Ortiz M, Martínez L, Lezana MA, López-Gatell H, Alpuche C. 2011. Perfil epidemiológico de la pandemia de la influenza A (H1N1) 2009 en México. Editorial Secretaría de Salud Subsecretaría de Prevención y Promoción de La Salud, Dirección General de Epidemiología. México DF, México.
4. Dauvilliers Y, Montplaisir J, Cochen V, Desauteis A, Einen M, Lin L, Kawashima M, Bayard S, Monaca C, Tiberge M, Filipini D, Tripathy A, Nguyen BH, Kotagal S, Mignot E. 2010. Post-H1N1 narcolepsy-cataplexy. Sleep 33: 1428-1430.
5. Diez-Domingo J, Garcés-Sanchez M, Baldó JM, Planelles MV, Ubeda I, JuBert A, Mares J, Moris P, Garcia Corbeira P, Dramé M, Gillard P. 2010. Immunogenicity and safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study. Pediatr Infect Dis J 29: 35-46.
6. Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jaïs C, Castot A, Damase-Michel C, Montastruc JL. 2011. National Campaign of Vaccination against the Flu A (H1N1)v: National Follow-up of Pharmacovigilance. Therapie 66: 527-540.
7. Izumi Y, Tokuda K, O'Dell KA, Zorumski CF, Narahashi T. 2007. Neuroexcitatory actions of Tamiflu and its carboxylate metabolite. Neurosciences Lett 426: 54-58.
8. Johansen K, Nicoll A, Ciancio BC, Kramarz P. 2009. Pandemic influenza A(H1N1) 2009 vaccines in the European Union. Euro Surveill 14: 19361.
9. Khan N, Mukhtar H. 2007. Tea polyphenols for health promotion. Life Sci 81: 519-533.
10. Kuzuhara T, Iwai Y, Takahashi, H, Hatakeyama D, Echigo N (2009). Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase. PLoS Currents Influenza October 13: rrn1052.
11. Marcus C. 2011. Association between narcolepsy and H1N1 exposure. Sleep 34: 687.
12. Ministerio de Salud de Chile. 2009. Influenza pandémica (H1N1) 2009. Reporte 15 de Diciembre de 2009. http://www.redsalud.gov.cl/minsalaudios/reporte15diciembre.pdf (Acceso el 31 de enero de 2012).
13. Reece PA. 2007. Neuroaminidase inhibitor resistance in Influenza viruses. J Med Virol 79: 1577-1586.
14. Sartippour MR, Heber D, Zhang L, Beatty P, Elashoff D, Elashoff R, Liang Go V, Brooks MN. 2002. Inhibition of fibroblast growth factors by green tea. Int J Oncol 21: 487-491.
15. Schwarz TF, Horacek T, Knuf M, Damman HG, Roman F, Dramé M, Gillard P, Jilq W. 2009. Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. Vaccine 27: 6284-6290.
16. Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant A. 2009. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomized controlled trials. BMJ 339: b3172.
17. Singh BN, Shankar S, Srivastava RK. 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82: 1807-1821.
18. WHO. 2005. Influenza pandemic preparedness and response. Report by the secretariat.
19. WHO. 2009a. Pandemic (H1N1)-update 72. http://www.who.int/csr/don/2009_10_30/en/index.html (Acceso el 31 de enero de 2012).
20. WHO. 2009b. New influenza A (H1N1) virus; global epidemiological situation. Weekly Epidemiol Rec 84: 249-257.
21. Yuan P, Bartlam M, Lou Z, Chen S, Zhou J, He X, Lv Z, Ge R, Li X, Deng T, Fodor E, Rao Z, Liu Y. 2009. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 458: 909-913.